Weight loss drug giant Novo Nordisk collaborates with two companies on research on new therapies for cardiovascular metabolic diseases
bmxphg274
发表于 2024-1-5 11:07:12
1295
0
0
On January 4th, Danish pharmaceutical company Novo Nordisk announced a separate research collaboration with two American biotech companies, Omega Therapeutics and Cellerity, on new therapies for cardiovascular metabolic diseases.
It is reported that Novo Nordisk is collaborating with Omega to develop an epigenome controller using the company's platform technology, aimed at enhancing metabolism as part of a potential new approach to obesity management. The collaboration between this Danish pharmaceutical company and Cellerity will build upon previous work and utilize the company's platform to develop a small molecule therapy for the treatment of metabolic dysfunction related fatty hepatitis (MASH).
Novo Nordisk stated that these are the first two projects signed under the framework cooperation between Flagship Pioneering and Novo Nordisk. Flagship Pioneering is a biotechnology company dedicated to investing in platforms and creating companies that can change the world. (Huo Xingyu)
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- After three years of implementing the "double reduction" policy, the performance of the four giants in education and training has reached a clear watershed
- The market value of the "Seven Giants" evaporated by $1.1 trillion in five days! Has a major stock market rotation occurred in the United States?
- US solar giant's stock price collapses, analysts warn the company is on the brink of delisting and bankruptcy
- When the giant goes to NVIDIA, Amazon's new AI chip exposure performance increases by up to 50%
- The 'darkest moment' of the 'seven giants' in the US stock market: $2 trillion market value evaporating, generative AI business difficult to make money
- US retail giant Target's US stock rose over 10% in pre-market trading
- Vaccine giant responds: nationwide suspension
- Iron ore giant, change of leadership
- After clocking in to work, I didn't come out again and was only discovered 4 days later! US trillion dollar banking giant, employee dies at workstation, police: investigating
- Cloud computing giant enters AI talent battle, acquires AI voice agency Tenyx
-
9月5日、蔚来は2024年第2四半期の財政報告を発表し、第2四半期の売上高は174億5000万元で、前年同期比98.9%増加した。今年第2四半期、蔚来は累計5万7400台の新車を納入した。 財報の発表当日、資本市場で前向きなフ ...
- 就放荡不羁就h
- 前天 12:39
- 支持
- 反对
- 回复
- 收藏
-
小鵬自動車の新車種MONA M 03は肇慶基地で順調に量産され、工事中の瑞慶時代二工場は年内に操業を開始する予定で、広州データ取引所(肇慶)サービス基地は看板を掲げて運営している……実体経済であれ、デジタル経 ...
- slim
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
JPモルガン・チェース首席米経済学者マイケル・フェローリ(Michael Feroli)氏は最近、FRBは9月の会議で金利を50ベーシスポイント引き下げなければならないと述べた。 現地時間の木曜日(9月5日)、フェリリ氏はメ ...
- 不正经的工程师
- 前天 21:44
- 支持
- 反对
- 回复
- 收藏
-
【クアルコムCEO:サムスンとグーグルと協力してハイブリッド現実眼鏡を開発中】クアルコムのクリスティア・アモン最高経営責任者は、クアルコムがサムスンとグーグルと協力してスマートフォンにつながるハイブリッ ...
- 寒郁轩良
- 前天 10:33
- 支持
- 反对
- 回复
- 收藏